Jazz Pharmaceuticals (JAZZ) has an average rating of overweight and mean price target of $259.28, according to analysts polled by FactSet.
(covers e281quity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $234.28, Change: $+5.09, Percent Change: +2.22%